Related Experiment Videos
Propylthiouracil hepatotoxicity. A review and case presentation
1Department of Paediatrics, Hospital for Sick Children, Toronto, Canada.
Clinical Pediatrics
|January 1, 1993
Summary
Propylthiouracil (PTU) can cause severe liver toxicity in hyperthyroid patients. Early recognition and steroid treatment are crucial for recovery, especially in pediatric cases.
Area of Science:
- Hepatology
- Pediatric Endocrinology
- Clinical Pharmacology
Background:
- Propylthiouracil (PTU) is a common antithyroid medication for hyperthyroidism.
- Severe hepatotoxicity is a rare but serious adverse effect of PTU.
- Monitoring for liver dysfunction is essential in patients on PTU therapy.
Observation:
- A 14-year-old female developed jaundice, hepatocellular dysfunction, and hepatomegaly while on PTU for hyperthyroidism.
- Her condition progressed to include paranoid ideation, lethargy, and edema.
- This represents one of the few reported pediatric cases of PTU-induced liver injury.
Findings:
- The patient showed clinical and laboratory improvement after three weeks of prednisone therapy.
- Prompt intervention with steroid therapy and PTU discontinuation may lead to recovery.
- PTU liver toxicity requires high clinical suspicion for timely diagnosis and management.
Implications:
- This case highlights the importance of vigilant monitoring for PTU-induced liver toxicity in all age groups.
- Pediatric patients may be particularly susceptible or present with severe manifestations.
- Early detection and intervention are critical to prevent potentially fatal outcomes associated with PTU hepatotoxicity.